Related Experiment Video
Updated: Jun 25, 2026

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
Published on: February 9, 2021
Melamine-contaminated powdered formula and urolithiasis in young children
Na Guan1, Qingfeng Fan, Jie Ding
1Peking University First Hospital, Beijing, China.
Insights
Melamine-contaminated formula exposure and prematurity are linked to urinary stones in infants. Affected children often lack typical symptoms, highlighting the need for targeted screening.
Area of Science:
- Pediatric Nephrology
- Toxicology
- Public Health
Background:
- A melamine contamination epidemic in Chinese baby formula caused urinary tract stones in infants.
- Clinical features and risk factors for these stones were not fully understood.
Purpose of the Study:
- To investigate the clinical manifestations and predisposing factors of urinary tract stones in infants exposed to melamine-contaminated formula.
- To identify risk factors associated with melamine-induced urolithiasis.
Main Methods:
- A questionnaire surveyed parents of children under 36 months regarding melamine exposure, symptoms, and stone risk factors.
- Urinalysis, renal and liver function tests, biochemical markers, calcium:creatinine ratio, and ultrasonography were performed.
- Infant formulas were categorized by melamine content: high (>500 ppm), moderate (<150 ppm), or none (0 ppm).
Main Results:
- Of 589 children, 421 ingested contaminated formula; 50 developed urinary stones.
- Children exposed to high-melamine formula were 7.0 times more likely to have stones than those with no exposure.
- Preterm infants had a 4.5 times higher risk of stones compared to term infants.
Conclusions:
- Prematurity and melamine-contaminated formula exposure are significant risk factors for urinary stones in infants.
- Affected children often presented without the typical signs and symptoms of urolithiasis, suggesting atypical presentation.
Background:
A recent epidemic of melamine contamination of baby formula in China has been associated with the development of urinary tract stones, though the clinical manifestations and predisposing factors are incompletely delineated.
Methods:
We administered a questionnaire to the parents of children 36 months of age or younger who were being screened for a history of exposure to melamine and symptoms of, and possible predisposing factors for, urinary tract stones. In addition, we performed urinalysis, renal-function and liver-function tests, urinary tests for biochemical markers and the calcium:creatinine ratio, and ultrasonography. Powdered-milk infant formulas were classified as having a high melamine content (>500 ppm), a moderate melamine content (<150 ppm), or no melamine (0 ppm); no formulas contained between 150 and 500 ppm of melamine.
Results:
Contaminated formula was ingested by 421 of 589 children. Fifty had urinary stones, including 8 who had not received melamine-contaminated formula; 112 were suspected to have stones; and 427 had no stones. Among children with stones, 5.9% had hematuria and 2.9% had leukocyturia, percentages that did not differ significantly from those among children who were suspected to have stones or those who did not have stones. Serum creatinine, urea nitrogen, and alanine aminotransferase levels were normal in the 22 children with stones who were tested. Four of the 41 children (9.8%) who had stones and in whom urinary markers of glomerular function were measured had evidence of abnormalities; none had tubular dysfunction. Children exposed to high-melamine formula were 7.0 times as likely to have stones as those exposed to no-melamine formula. Preterm infants were 4.5 times as likely to have stones as term infants.
Conclusions:
Prematurity and exposure to melamine-contaminated formula were associated with urinary stones. Affected children lacked typical signs and symptoms of urolithiasis.
Related Concept Videos
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Urinary Tract Calculi I: Introduction
Urinary Tract Calculi V: Nursing Management
Pharmacokinetics in Pediatric Patients: Drug Excretion
